Suppr超能文献

“所有患者”行经心尖主动脉瓣置换术的临床和血液动力学结局:来自意大利经心尖主动脉瓣置换术注册研究(I-TA)的结果。

Clinical and hemodynamic outcomes of "all-comers" undergoing transapical aortic valve implantation: results from the Italian Registry of Trans-Apical Aortic Valve Implantation (I-TA).

机构信息

Division of Cardiac Surgery, University of Padova, Padova, Italy.

出版信息

J Thorac Cardiovasc Surg. 2011 Oct;142(4):768-75. doi: 10.1016/j.jtcvs.2011.06.026. Epub 2011 Aug 12.

Abstract

OBJECTIVE

The aim of this study was to assess clinical and hemodynamic outcomes of transapical aortic valve implantation (TA-TAVI) in patients enrolled in the Italian Registry of Trans-Apical Aortic Valve Implantation (I-TA).

METHODS

From April 2008 until November 2010, 504 patients from 20 Italian centers were enrolled in the I-TA registry. Mean logistic EuroSCORE and Society of Thoracic Surgeons score were 24% ± 16% and 11% ± 4%, respectively. Mean follow-up was 9.2 ± 6.5 months (range, 1-26 months). Outcomes were analyzed according to intraoperative complications, procedural volume (high-volume centers, >20 cases; low-volume centers, < 20 cases) and learning curve (first 50% cases vs second 50% cases of each center).

RESULTS

All-cause overall mortality was 8.3% (42 patients). Device success was 99% (500/504 patients). Intraoperative severe complications occurred in 24 (4.8%) patients. Overall 2-year survival was 71.5% ± 6.2%. At discharge, peak and mean gradients were 16.4 ± 11.2 and 8.7 ± 4.1 mm Hg, respectively, and effective orifice area was 1.67 cm(2). These values remained stable at 3, 6, and 12 months after surgery. Independent risk factors for mortality after TA-TAVI were as follows: New York Heart Association class III and IV (odds ratio [OR], 4.43; 95% confidence intervals [CI], 1.28-15.40; P = .02); logistic EuroSCORE greater than 20 (OR, 1.83; 95% CI, 1.02-3.29; P = .04); creatinine concentration greater than 200 μmol/L (OR, 2.56; 95% CI, 1.07-6.15; P = .03), and intraoperative complications (OR, 5.80; 95% CI, 2.68-12.55; P < .001). There were no significant differences in outcomes between high- and low-volume centers and between the first and the second 50% of cases.

CONCLUSIONS

TA-TAVI represents a safe and effective alternative treatment for patients who are inoperable or at high risk for surgery. The occurrence of an intraoperative complication significantly affects survival. Procedural volume and learning curve have no impact on patient survival.

摘要

目的

本研究旨在评估意大利经心尖主动脉瓣植入术(TA-TAVI)注册研究中入组患者的临床和血流动力学结果。

方法

2008 年 4 月至 2010 年 11 月,20 家意大利中心的 504 例患者入组该研究。平均 logistic EuroSCORE 和胸外科医师协会评分分别为 24%±16%和 11%±4%。平均随访时间为 9.2±6.5 个月(1-26 个月)。根据术中并发症、手术量(高容量中心>20 例;低容量中心<20 例)和学习曲线(每个中心前 50%病例与后 50%病例)分析结果。

结果

全因死亡率为 8.3%(42 例)。器械成功率为 99%(500/504 例)。术中发生严重并发症 24 例(4.8%)。总的 2 年生存率为 71.5%±6.2%。出院时,峰值和平均跨瓣压差分别为 16.4±11.2mmHg 和 8.7±4.1mmHg,有效瓣口面积为 1.67cm²。术后 3、6 和 12 个月时,这些值保持稳定。TA-TAVI 后死亡的独立危险因素包括:纽约心脏协会心功能分级 III 级和 IV 级(比值比[OR],4.43;95%置信区间[CI],1.28-15.40;P=0.02);logistic EuroSCORE 评分>20(OR,1.83;95%CI,1.02-3.29;P=0.04);肌酐浓度>200μmol/L(OR,2.56;95%CI,1.07-6.15;P=0.03)和术中并发症(OR,5.80;95%CI,2.68-12.55;P<0.001)。高容量中心与低容量中心、每个中心前 50%病例与后 50%病例之间的结果无显著差异。

结论

TA-TAVI 是一种安全有效的治疗方法,适用于不能手术或手术风险高的患者。术中并发症的发生显著影响生存率。手术量和学习曲线对患者生存率无影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验